In order to more efficiently utilize gypsum to improve meadow alkali soil slightly salinized by soda and sulfate chloride, a total of 27 treatments were de- signed from the perspectives of field capacity, alkalinity, ...In order to more efficiently utilize gypsum to improve meadow alkali soil slightly salinized by soda and sulfate chloride, a total of 27 treatments were de- signed from the perspectives of field capacity, alkalinity, alkaline salt content, optimal irrigation, gypsum conversion, gypsum and soil treatment and improvement depth. The ions on the obtained filtrate were analyzed in terms of salts. The improving ef- ficiency of gypsum for meadow alkali soil was analyzed through comparing the con- tents of soluble salts in pre-improvement and post-improvement soil by reasoning and calculation. The results showed that, （1） the dissolved amount and conversion amount of gypsum were increased, and the soil alkalinity was decreased corre- spondingly with the increased irrigation amount. However, after reaching a certain extent, the linear relationships became unobvious gradually. Therefore, the irrigation amount should be arranged reasonably for different treatment. （2） Compared with those at low temperature, the dissolved amount of gypsum at high temperature was increased by 1.47-1.50 times, the release amount of exchangeable sodium was in- creased by 2.98-4.70 times, and the release amount of exchangeable magnesium was increased by 2.07-2.90 times. In overall, the improving efficiency of gypsum in summer was better. However, gypsum had two shortcomings in summer. First, a large amount of gypsum leaked away. Second, a large amount of exchangeable magnesium, along with exchangeable sodium, was substituted by gypsum. （3） Compared with the other two treatments, treatment B （mixing gypsum and top 20- cm soil） showed the best improving efficiency, and it was characterized by stepwise dealkalization from top to down. In addition, mixing gypsum and topsoil is more practical in the production.展开更多
AIM:To compare the effects of telbivudine (LDT) and entecavir (ETV) in treatment of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B by meta-analysis. METHODS:We conducted a literature search using PubMed, M...AIM:To compare the effects of telbivudine (LDT) and entecavir (ETV) in treatment of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B by meta-analysis. METHODS:We conducted a literature search using PubMed, MEDLINE, EMBASE, the China National Knowledge Infrastructure, the VIP database, the Wanfang database and the Cochrane Controlled Trial Register for all relevant articles published before April 1, 2012. Randomized controlled trials (RCTs) comparing LDT with ETV for treatment of HBeAg-positive chronic hepatitis B were included. The data was analyzed with Review Manager Software 5.0. We used relative risk (RR) as an effect measure, and reported its 95% CI. Meta-analysis was performed using either a fixedeffect or random-effect model, based on the absence or presence of significant heterogeneity. Two reviewers assessed the risk of bias and extracted data indepen- dently and in duplicate. The analysis was executed using the main outcome parameters including hepatitis B virus (HBV) DNA undetectability, alanine aminotransferase (ALT) normalization, HBeAg loss, HBeAg seroconversion, drug-resistance, and adverse reactions. Meta-analysis of the included trials and subgroup analyses were conducted to examine the association between pre-specified characteristics with the therapeutic effects of the two agents. RESULTS:Thirteen eligible trials (3925 patients in total) were included and evaluated for methodological quality and heterogeneity. In various treatment durations of 4 wk, 8 wk, 12 wk, 24 wk, 36 wk, 48 wk, 52 wk, 60 wk and 72 wk, the rates of HBV DNA undetectability and ALT normalization in the two groups were similar, without statistical significance. At 4 wk and 8 wk of the treatment, no statistical differences were found in the rate of HBeAg loss between the two groups, while the rate in the LDT group was higher than in the ETV group at 12 wk, 24 wk, 48 wk and 52 wk, respectively (RR 2.28, 95% CI 1.16, 7.03, P = 0.02; RR 1.45, 95% CI 1.16, 1.82, P = 0.001; RR 1.45, 95% CI 1.11, 1.89, P = 0.006; and RR 1.86, 95% CI 1.04, 3.32, P = 0.04). At 4 wk, 8 wk, 60 wk and 72 wk of the treatment, there were no significant differences in the rate of HBeAg seroconversion between the two groups, while at 12 wk, 24 wk, 48 wk and 52 wk, the rate in the LDT group was higher than in the ETV group (RR 2.10, 95% CI 1.36, 3.24, P = 0.0008; RR 1.71, 95% CI 1.29, 2.28, P = 0.0002; RR 1.86, 95% CI 1.36, 2.54, P < 0.0001; and RR 1.87, 95% CI 1.21, 2.90, P = 0.005). The rate of drug-resistance was higher in the LDT group than in the ETV group (RR 3.76, 95% CI 1.28, 11.01, P = 0.02). In addition, no severe adverse drug reactions were observed in the two groups. And the rate of increased creatine kinase in the LDT group was higher than in the ETV group (RR 5.58, 95% CI 2.22, 13.98, P = 0.0002). CONCLUSION:LDT and ETV have similar virological and biomedical responses, and both are safe and well tolerated. However, LDT has better serological response and higher drug-resistance.展开更多
基金Supported by National Natural Science Foundation of China(41401559)Project of Hubei Provincial Science and Technology Department(2014CFB558)Project of Hubei Provincial Department of Education(D20141001)~~
文摘In order to more efficiently utilize gypsum to improve meadow alkali soil slightly salinized by soda and sulfate chloride, a total of 27 treatments were de- signed from the perspectives of field capacity, alkalinity, alkaline salt content, optimal irrigation, gypsum conversion, gypsum and soil treatment and improvement depth. The ions on the obtained filtrate were analyzed in terms of salts. The improving ef- ficiency of gypsum for meadow alkali soil was analyzed through comparing the con- tents of soluble salts in pre-improvement and post-improvement soil by reasoning and calculation. The results showed that, （1） the dissolved amount and conversion amount of gypsum were increased, and the soil alkalinity was decreased corre- spondingly with the increased irrigation amount. However, after reaching a certain extent, the linear relationships became unobvious gradually. Therefore, the irrigation amount should be arranged reasonably for different treatment. （2） Compared with those at low temperature, the dissolved amount of gypsum at high temperature was increased by 1.47-1.50 times, the release amount of exchangeable sodium was in- creased by 2.98-4.70 times, and the release amount of exchangeable magnesium was increased by 2.07-2.90 times. In overall, the improving efficiency of gypsum in summer was better. However, gypsum had two shortcomings in summer. First, a large amount of gypsum leaked away. Second, a large amount of exchangeable magnesium, along with exchangeable sodium, was substituted by gypsum. （3） Compared with the other two treatments, treatment B （mixing gypsum and top 20- cm soil） showed the best improving efficiency, and it was characterized by stepwise dealkalization from top to down. In addition, mixing gypsum and topsoil is more practical in the production.
基金Supported by Drug Research Fund of Hepatitis, Guangdong Pharmaceutical Association, No. 2012G01
文摘AIM:To compare the effects of telbivudine (LDT) and entecavir (ETV) in treatment of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B by meta-analysis. METHODS:We conducted a literature search using PubMed, MEDLINE, EMBASE, the China National Knowledge Infrastructure, the VIP database, the Wanfang database and the Cochrane Controlled Trial Register for all relevant articles published before April 1, 2012. Randomized controlled trials (RCTs) comparing LDT with ETV for treatment of HBeAg-positive chronic hepatitis B were included. The data was analyzed with Review Manager Software 5.0. We used relative risk (RR) as an effect measure, and reported its 95% CI. Meta-analysis was performed using either a fixedeffect or random-effect model, based on the absence or presence of significant heterogeneity. Two reviewers assessed the risk of bias and extracted data indepen- dently and in duplicate. The analysis was executed using the main outcome parameters including hepatitis B virus (HBV) DNA undetectability, alanine aminotransferase (ALT) normalization, HBeAg loss, HBeAg seroconversion, drug-resistance, and adverse reactions. Meta-analysis of the included trials and subgroup analyses were conducted to examine the association between pre-specified characteristics with the therapeutic effects of the two agents. RESULTS:Thirteen eligible trials (3925 patients in total) were included and evaluated for methodological quality and heterogeneity. In various treatment durations of 4 wk, 8 wk, 12 wk, 24 wk, 36 wk, 48 wk, 52 wk, 60 wk and 72 wk, the rates of HBV DNA undetectability and ALT normalization in the two groups were similar, without statistical significance. At 4 wk and 8 wk of the treatment, no statistical differences were found in the rate of HBeAg loss between the two groups, while the rate in the LDT group was higher than in the ETV group at 12 wk, 24 wk, 48 wk and 52 wk, respectively (RR 2.28, 95% CI 1.16, 7.03, P = 0.02; RR 1.45, 95% CI 1.16, 1.82, P = 0.001; RR 1.45, 95% CI 1.11, 1.89, P = 0.006; and RR 1.86, 95% CI 1.04, 3.32, P = 0.04). At 4 wk, 8 wk, 60 wk and 72 wk of the treatment, there were no significant differences in the rate of HBeAg seroconversion between the two groups, while at 12 wk, 24 wk, 48 wk and 52 wk, the rate in the LDT group was higher than in the ETV group (RR 2.10, 95% CI 1.36, 3.24, P = 0.0008; RR 1.71, 95% CI 1.29, 2.28, P = 0.0002; RR 1.86, 95% CI 1.36, 2.54, P < 0.0001; and RR 1.87, 95% CI 1.21, 2.90, P = 0.005). The rate of drug-resistance was higher in the LDT group than in the ETV group (RR 3.76, 95% CI 1.28, 11.01, P = 0.02). In addition, no severe adverse drug reactions were observed in the two groups. And the rate of increased creatine kinase in the LDT group was higher than in the ETV group (RR 5.58, 95% CI 2.22, 13.98, P = 0.0002). CONCLUSION:LDT and ETV have similar virological and biomedical responses, and both are safe and well tolerated. However, LDT has better serological response and higher drug-resistance.
